During the past decade, Aulss 3 Serenissima, Ospedale Dell'Angelo - Mestre - Uo Ematologia conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aulss 3 Serenissima, Ospedale Dell'Angelo - Mestre - Uo Ematologia" #1 collaborator was "Associazione Italiana per la Ricerca sul Cancro" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Aulss 3 Serenissima, Ospedale Dell'Angelo - Mestre - Uo Ematologia" are "Acute Lymphoblastic Leukemia" (5 trials), "Acute Lymphoid Leukemia" (2 trials), "Acute Myeloid Leukemia" (2 trials), "Philadelphia-Positive ALL" (2 trials) and "ALL, Adult" (1 trials). Many other conditions were trialed in "Aulss 3 Serenissima, Ospedale Dell'Angelo - Mestre - Uo Ematologia" in a lesser frequency.

Most popular intervention types in "Aulss 3 Serenissima, Ospedale Dell'Angelo - Mestre - Uo Ematologia" are "Drug" (16 trials), "Behavioral" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nilotinib" (2 trials), "Ponatinib" (2 trials), "Allogeneic SCT or Autologous SCT" (1 trials), "Blinatumomab" (1 trials) and "Caspofungin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aulss 3 Serenissima, Ospedale Dell'Angelo - Mestre - Uo Ematologia" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Aulss 3 Serenissima, Ospedale Dell'Angelo - Mestre - Uo Ematologia". undefined are not yet recruiting, 9 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Aulss 3 Serenissima, Ospedale Dell'Angelo - Mestre - Uo Ematologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aulss 3 Serenissima, Ospedale Dell'Angelo - Mestre - Uo Ematologia, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".